Background-Suppressor of cytokine signaling-3 (SOCS3) is a key negative-feedback regulator of the gp130 receptor that provides crucial signaling for cardiac hypertrophy and survival; however, an in vivo role of SOCS3 regulation on cardiac gp130 signaling remains obscure. Methods and Results-We generated cardiac-specific SOCS3 knockout (SOCS3 cKO) mice. These mice showed increased activation of gp130 downstream signaling targets (STAT3, ERK1/2, AKT, and p38) from 15 weeks of age and developed cardiac dysfunction from approximately 25 weeks of age with signs of heart failure. Surprisingly, SOCS3 cKO failing hearts had minimal histological abnormalities with intact myofibril ultrastructure. In addition, Ca 2ϩ transients were significantly increased in SOCS3 cKO failing hearts compared with wild-type hearts. We also found that Ser23/24 residues of troponin I were hypophosphorylated in SOCS3 cKO hearts before the manifestation of cardiac dysfunction. These data suggested the presence of abnormalities in myofilament Ca 2ϩ sensitivity in SOCS3 cKO mice. In addition to the contractile dysfunction, we found various ventricular arrhythmias in SOCS3 cKO nonfailing hearts accompanied by a sarcoplasmic reticulum Ca 2ϩ overload. To determine the contribution of gp130 signaling to the cardiac phenotype that occurs with SOCS3 deficiency, we generated cardiac-specific gp130 and SOCS3 double KO mice. Double KO mice lived significantly longer and had different histological abnormalities when compared with SOCS3 cKO mice, thus demonstrating the importance of gp130 signaling in the SOCS3 cKO cardiac phenotype. Conclusions-Our results demonstrate an important role of SOCS3 regulation on cardiac gp130 signaling in the pathogenesis of contractile dysfunction and ventricular arrhythmias. (Circulation. 2011;124:00-00.)
S
uppressor of cytokine signaling-3 (SOCS3) is a key negative-feedback regulator of gp130, which is a common receptor component of the interleukin-6 (IL-6) family of cytokines. The IL-6 family of cytokines activates the JAK-STAT signaling pathway through gp130 and induces the expression of the cytokine-responsive genes, including SOCS3. Subsequently, SOCS3 binds to gp130 and inhibits the downstream signaling cascade that includes activation of JAK-STAT, SH2 homology containing tyrosine phosphatase 2 (SHP2)-Ras/ERK, and SHP2-AKT. [1] [2] [3] Accordingly, SOCS3 tightly regulates the duration and intensity of gp130 signaling in a classic negative-feedback manner.
Whereas cardiac gp130 signaling has been shown to significantly affect cardiomyocyte survival following acute pressure overload, the role of SOCS3 regulation on cardiac gp130 signaling remains unclear. 4 
Clinical Perspective on p••
Germline knockout (KO) of SOCS3 causes embryonic lethality via placental deficiency associated with an abnormality of trophoblast giant cell differentiation. 5, 6 When placental deficiency is rescued by a tetraploid embryo complementation approach, SOCS3 KO embryos show a perinatal lethality with a markedly enlarged heart and hypertrophy.
Furthermore, the placental defect and cardiac abnormalities can be rescued in the embryos with leukemia inhibitory factor receptor null background. 6 These data demonstrate that SOCS3 is an essential regulator of LIF-gp130 signaling. Moreover, these data suggest that unregulated gp130 activation without SOCS3 regulation leads to cardiac hypertrophy during embryonic development. However, due to embryonic lethality, the ultimate physiological role of SOCS3 regulation on gp130 signaling in the adult heart remains unclear.
In isolated adult cardiomyocytes, gp130 stimulation by IL-6 has been reported to decrease myocyte contractility during acute exposure. In addition, chronic IL-6 stimulation induces cardiac hypertrophy. [7] [8] [9] These findings indicate a potentially pathological role of gp130 signaling in the cardiomyocyte. In humans, the serum level of IL-6 is known to be elevated in patients with congestive heart failure (CHF), and the elevated levels correspond to worsening functional class, increased hospitalization rates, and poor survival. 10 -12 In the Framingham Heart Study, elevated serum IL-6 has been associated with increased risk of CHF in elderly subjects without prior myocardial infarction. 13 Furthermore, during heart transplant, myocardial IL-6 expression has been reported to be significantly increased in donor hearts with dysfunction compared with those with normal function. 14 Despite the strong association between the activation of gp130 signaling and CHF in humans, the primary role of gp130 activation during the development of cardiac dysfunction has not been thoroughly evaluated using animal models.
It has been reported that SOCS3 protein and mRNA levels are decreased in failing human myocardium. [15] [16] [17] In many cancer cells, the hypermethylation of CpG islands in the SOCS3 promoter inhibits the transcription of SOCS3 mRNA, resulting in epigenetic silencing of SOCS3 protein. 18, 19 These data suggest that abnormalities of SOCS3 regulation on cardiac gp130 signaling could occur in diseased states.
Accordingly, we hypothesized that the loss of gp130-mediated upregulation of SOCS3 induces sustained activation of gp130 signaling in the cardiomyocyte, leading to cardiomyopathy and heart failure. In this study, we found that the absence of SOCS3 regulation in the cardiomyocyte results in early mortality that is inhibited by deletion of gp130 and is accompanied by contractile dysfunction and ventricular arrhythmias. These findings highlight a crucial role of SOCS3 and its apparent effect on gp130 signaling in the homeostasis of adult cardiomyocytes and demonstrate a previously unidentified role of gp130 signaling in the pathogenesis of cardiomyopathy.
Methods

Mice
Floxed SOCS3 (SOCS3 F/ϩ , a kind gift from Dr Kenneth R. Chien, MGH), 20 floxed gp130 (gp130 F/ϩ ), 21 and ␣-myosin heavy chain-Cre mice were bred in UCSD vivarium according to institutional guidelines. These mice were backcrossed into Balb/c for at least 5 generations.
Immunoblot Analysis and Antibodies
Protein extraction and Western blot analysis were performed as described previously. 21 Primary antibodies used were rabbit anti-STAT3, p-STAT3, p-STAT1, ERK1/2, p-ERK1/2, AKT, p-AKT, p38, p-p38, JNK, p-JNK, Caspase-3, p-TnI, TnI, p-PKA C, and PKA C (cell signaling); rabbit anti-SCN5A and Cav1.2a (Alamone Labs); rabbit anti-SOCS3 (AnaSpec Inc.) and anti-CASQ2 (H-60) (Santa Cruz); mouse anti-RyR, NCX1, KCNQ1, and rabbit anti-KCNH2 (Abcam); mouse anti-SERCA2a (Thermo Scientific); and rabbit antip-PLB (Ser16) (Badrilla).
Echocardiogram
Mice were anesthetized with 1% isoflurane. Recording was performed using a Sonos 5500 (Philips) with a 15-MHz probe as described previously. 21 
Adult Cardiomyocyte Isolation
Cardiomyocytes were isolated as described previously. 21 For wheat germ agglutinin staining, the cardiomyocytes were plated on lamininprecoated plates (10 mg/mL, Sigma) for 1 hour and fixed with 10% buffered formalin for 5 minutes, followed by washing with PBS.
Ca
2؉ Transients and Sarcomere Shortening Measurement
The measurements were performed as outlined previously. 22, 23 The specific conditions are described in online-only Data Supplement Methods.
Telemetry ECG
For unanesthetized ECG studies, an ECG transmitter TA10ETA-F20 or TA10EA-F20 (DSI) was subcutaneously inserted into the backs of the mice. Positive and negative leads were fixed to the right shoulder muscle and the left leg muscle, respectively. To exclude the effect of injury due to the surgery, data were collected for 24 hours after a 1-week recovery period.
Statistical Analysis
Data are shown by box plot, and statistical significance was evaluated using Mann-Whitney U test unless otherwise noted. The high and low lines on the box plots represent the 90th and 10th percentiles of the data, respectively. Differences in cardiomyocyte size between knockout and littermate control mice were analyzed using paired t test. The changes in echo data before and after transverse aortic constriction in wild-type (WT) and SOCS3 cKO mice were compared using repeated-measure ANOVA. For multiple comparisons, 1-way ANOVA using a Tukey-Kramer post hoc test was used. Linear regression analysis was performed using least squares method. For survival rate, the differences between 2 groups were analyzed by Logrank (Mantel-Cox) test; probability values Ͻ0.05 were considered statistically significant.
Results
Generation of Cardiac-Specific SOCS3 KO Mice
Cardiac-specific SOCS3 KO (SOCS3 cKO) mice were generated by breeding floxed SOCS3 mice with ␣-myosin heavy chain-Cre transgenic mice. 20 These mice were born at expected Mendelian ratios and were fertile. To confirm that there was functional disruption of SOCS3 in the heart, we stimulated isolated adult cardiomyocytes with cardiotrophin-1 (CT-1), a known gp130 activator. After rapid phosphorylation of STAT3, maximal expression of SOCS3 protein in WT cardiomyocytes was observed 4 hours post CT-1 stimulation with diminished STAT3 phosphorylation. In contrast, we observed no detectable SOCS3 expression in SOCS3 cKO cardiomyocytes post CT-1 stimulation. Moreover, this resulted in sustained STAT3 activation in the SOCS3 KO cardiomyocytes ( Figure 1A ). These results demonstrated the functional disruption of SOCS3 in cardiomyocytes from SOCS3 cKO mice.
Activation of Cardiac gp130 Signaling in SOCS3 cKO Mice
To evaluate the activation of cardiac gp130 signaling in SOCS3 cKO mice, we examined known gp130 downstream signaling molecules. Phosphorylation of STAT3, ERK1/2, AKT, and p38 were significantly increased in SOCS3 cKO hearts compared with WT at 15 weeks of age, whereas no significant differences were observed at 8 weeks of age ( Figure 1B ). These data suggested the sustained activation of cardiac gp130 signaling in SOCS3 cKO mice by 15 weeks of age. To find potential ligands for the activation of gp130 signaling, we investigated IL-6, LIF, and CT-1 mRNA levels by quantitative PCR and found the significant increase only in CT-1 in both WT and SOCS3 cKO hearts at 15 weeks of age (online-only Data Supplement Figure I ). This suggested the physiological activation of cardiac gp130 signaling by CT-1 during postnatal cardiac development.
SOCS3 cKO Mice Develop Dilated Cardiomyopathy (DCM)
SOCS3 cKO mice had early mortality and died by 33 weeks of age (Figure 2A ). Dying mice showed signs of dyspnea and had significant pleural effusions and ascites with enlarged atria and ventricles ( Figure 2B , left panel). Ventricular weight to tibia length ratio (VW/TL) was significantly increased in SOCS3 cKO compared with WT mice at 28 weeks of age ( Figure 2B , right panel). Isolated cardiomyocytes from SOCS3 cKO failing hearts were significantly wider and longer than those from gender-matched WT littermates (Figure 2C) . Echocardiographic analyses of SOCS3 cKO mice showed significantly decreased cardiac function with dilated left ventricular (LV) cavity compared with WT from Ϸ25 weeks of age ( Figure 2D ). To assess the presence of a potential nonspecific effect of Cre overexpression on cardiac function, cardiac-specific heterozygous SOCS3 cKO mice 28 weeks of age (SOCS3 F/ϩ , Cre) were evaluated by echocardiography. We observed no significant cardiac dysfunction in these mice (mean fractional shortening [FS] 40.8Ϯ5.9%, nϭ4, Pϭ0.6). These results demonstrated that SOCS3 cKO mice developed DCM, resulting in heart failure and early mortality. The fact that cardiac gp130 signaling was activated before manifestation of the cardiac dysfunction suggested a causative association between unregulated gp130 activation and heart failure in SOCS3 cKO mice ( Figures 1B and 2D ).
Minimal Histological Abnormalities in SOCS3 cKO Failing Hearts
Despite the severe cardiac dysfunction, there was no obvious cardiomyocyte disarray, necrosis, inflammation, or interstitial fibrosis in SOCS3 cKO failing hearts ( Figure 2E , left panel). Consistent with the minimal interstitial fibrosis, levels of matrix metalloproteinase (MMP)-9 and -2 in SOCS3 cKO failing hearts were equivalent to those in WT hearts (onlineonly Data Supplement Figure II ). The ultrastructure of the myofibrils was also intact, with clear A, I, Z, and M-bands ( Figure 2E , right panel). We also examined the activation of apoptosis in the SOCS3 cKO failing hearts; however, there was no significant increase in TUNEL-positive cardiomyocytes ( Figure 2F , left panel). Furthermore, caspase-3 cleavage was not detectable in the failing hearts by Western blot ( Figure 2F , right panel). These data strongly suggested the presence of nonstructural abnormalities in SOCS3 cKO failing hearts.
SOCS3 cKO Mice Showed Cardiac Dysfunction Under Acute-Pressure Overload
It has been reported that gp130 signaling is activated in the heart under acute-pressure overload induced by transverse aortic constriction (TAC). 4 ,24 Therefore, we examined the effect of TAC on cardiac function by echocardiography using 8-week-old SOCS3 cKO mice. Cardiac function was significantly decreased with left ventricular (LV) chamber dilatation in SOCS3 cKO compared with WT mice 10 days post-TAC surgery. LV weight and tibial length ratio (LV/TL) was also significantly increased in SOCS3 cKO mice ( Figure  3A ). Consistently, p-STAT3, p-ERK1/2, and p-AKT were significantly increased in SOCS3 cKO hearts 10 days post TAC ( Figure 3B ), whereas there were no significant differences in the signaling between sham-operated WT and SOCS3 cKO mice at this age (online-only Data Supplement Figure III ). These results indicated the association between Heart failure and early mortality in SOCS3 cKO mice. A, Kaplan-Meier survival curves of wild-type (WT) and SOCS3 cKO mice. B, Morphology of SOCS3 cKO failing heart (28 weeks old). Mural thrombus in left atrium (arrow) was frequently observed in SOCS3 cKO mice. Scale barsϭ1 mm. Ventricular weight to tibia length ratio (VW/TL) is shown in the panel on the right. C, Isolated cardiomyocytes were stained with wheat germ agglutinin conjugated with Texas Red to visualize the sarcolemma membrane clearly (left panels). Width and length of SOCS3 cKO cardiomyocyte were calculated relative to that of WT cardiomyocytes (right panel). Scale barsϭ100 m. D, Echocardiography at 8, 20, 25, and 28 weeks of age (different groups of mice, nϭ5 in each group, were used at each time point). Representative M-mode images are shown on the top. LVEDD indicates left ventricular end-diastolic dimension; LVESD, LV end-systolic dimension; %FS, percent fractional shortening. E, Hematoxylin-eosin (HE) and Masson-Trichrome (MT) staining of WT nonfailing and SOCS3 cKO failing heart sections (28 weeks old, left panels). Scale barsϭ100 m (HE) and 200 m (MT). Ultrastructure of myofibrils in WT nonfailing and SOCS3 cKO failing hearts by electron microscopy (right panels). Scale barsϭ1.5 m. F, A representative TUNEL staining of the SOCS3 cKO failing heart using the spleen tissue from the same animal as a positive control (left panels). All the TUNEL-positive cells in the heart were blood cells in capillaries (left panel, arrow). Caspase-3 (Casp3) cleavage was examined by Western blot using anti-casp3 antibody that can detect both cleaved and uncleaved Casp3 (right panel). Scale barϭ200 m. *PϽ0.05 comparing SOCS3 cKO with WT. unregulated gp130 activation and cardiac dysfunction in SOCS3 cKO mice under acute-pressure overload.
Increase in Ca 2؉ Transients and Abnormal Myofilament Ca 2؉ Sensitivity in SOCS3 cKO Failing Cardiomyocytes
Given that there were no obvious structural abnormalities in the SOCS3 cKO failing heart, we examined Ca 2ϩ transients and twitch contraction using isolated cardiomyocytes from SOCS3 cKO failing hearts (28 weeks old). Unexpectedly, SOCS3 cKO cardiomyocytes had significantly higher Ca 2ϩ transients with a longer time constant of [Ca 2ϩ ] i decline compared with age-matched WT cardiomyocytes ( Figure 4A , upper panels). The time constant of relaxation was significantly prolonged in SOCS3 cKO cardiomyocytes, whereas there was no significant difference in maximal shortening between the two groups ( Figure 4A , lower panels). We next analyzed the relationship between peak [Ca 2ϩ ] i and %sarco-mere shortening in the scatter-plot graph. The %sarcomere shortening was increased in proportion to the increase in peak [Ca 2ϩ ] i in WT cardiomyocytes (R 2 ϭ0.896). In contrast, the proportional relationship was absent in SOCS3 cKO cardiomyocytes ( Figure 4B ). These results demonstrated the presence of abnormalities in relaxation and myofilament Ca 2ϩ sensitivity in SOCS3 cKO cardiomyocytes. Given the increase in Ca 2ϩ transients, we subsequently examined the expression level of sarcoplasmic reticulum (SR) proteins. Although there were no abnormalities in SR Ca 2ϩ -ATPase (SERCA2a), phosphorylated phospholamban (p-PLB, Ser16), and endogenous PLB, we found a significant increase in cardiac calsequestrin (CASQ2) in SOCS3 cKO failing hearts ( Figure 4C ). Given that cardiac calsequestrin is the major Ca 2ϩ binding protein in SR, these data implied an increase in SR Ca 2ϩ contents in SOCS3 cKO cardiomyocytes. Furthermore, we frequently observed triggered activities in SOCS3 cKO failing cardiomyocytes during the Ca 2ϩ transient recording when stimulated with 1.0 Hz ( Figure 4D , upper panel). Interestingly, short coupling of the triggered activity sometimes induced abnormal automaticity followed by fibrillation ( Figure 4D , lower panel). These results indicated the presence of an electric instability in SOCS3 cKO failing hearts.
SR Ca 2؉ Overload and Ventricular Arrhythmias in SOCS3 cKO Nonfailing Heart
To exclude the secondary effects due to the cardiomyopathy, we investigated Ca 2ϩ transients and SR Ca 2ϩ contents in the SOCS3 cKO nonfailing cardiomyocytes (20 weeks old). We found significantly higher Ca 2ϩ transients and SR Ca 2ϩ contents in SOCS3 cKO compared with age-matched WT cardiomyocytes, indicating the presence of SR Ca 2ϩ overload in SOCS3 cKO, nonfailing hearts ( Figure 5A ). Moreover, we found a variety of ventricular arrhythmias such as premature ventricular contraction and aberrancy in ventricular conduction including the possibility of ventricular tachycardia in SOCS3 cKO mice with normal cardiac function ( Figure 5B and 5C ). These results indicated the increase in arrhythmogenicity caused by SR Ca 2ϩ overload in SOCS3 cKO mice.
Unregulated gp130-STAT3 Activation Led to an Increase in Cardiac Voltage-Gated Sodium Channel (SCN5A) in SOCS3 cKO Cardiomyocyte
Because we detected SR Ca 2ϩ overload in SOCS3 cKO hearts, we subsequently examined the expression level of proteins that can affect Ca 2ϩ transients and SR Ca 2ϩ content; however, there were no significant abnormalities in the expression of PLB, SERCA2a, Ryanodine receptor 2 (RyR2), Na ϩ -Ca 2ϩ exchanger (NCX1), L-type Ca 2ϩ channel (Cav1.2a), and potassium channels (KCNH2 and KCNQ1) (online-only Data Supplement Figure IV) . In contrast, we found a significant increase in SCN5A protein and mRNA in SOCS3 cKO nonfailing hearts ( Figure 5D and online-only Data Supplement Figure VA) . To examine whether the gp130 Figure 3 . SOCS3 cKO mice developed cardiac dysfunction under acute pressure overload. A, Echocardiography before transverse aortic constriction (TAC) (Pre TAC) and 10 days after TAC (Post TAC) (8 weeks old, female, nϭ6 and 7, respectively). The changes in echo data before and after TAC were compared between the two groups using repeated-measure ANOVA (*PϽ0.05). As a control, sham-operated mice (nϭ5 in each group) were also examined at 10 days. PG indicates pressure gradient between right and left carotid arteries measured 10 days post TAC; LV/TL, LV weight and tibia length ratio. B, Activation of STAT3, ERK1/2, and AKT signaling in the heart 10 days after TAC. **PϽ0.05 comparing SOCS3 cKO with WT.
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activation directly increases SCN5A mRNA, we stimulated isolated WT and SOCS3 cKO cardiomyocytes with CT-1. We found a significant increase in SCN5A mRNA in SOCS3 cKO cardiomyocytes 4 hours post CT-1 stimulation, whereas there were no such increases in WT cardiomyocytes ( Figure  6A ). To identify which signaling pathway may be responsible for the effect of gp130 signaling on the increased SCN5A mRNA, we inhibited STAT3 activation in SOCS3 cKO cardiomyocytes using adenoviral vector expressing dominant-negative STAT3 (dnSTAT3) ( Figure 6B , left panel). 21 The inhibition of STAT3 activation significantly decreased the SCN5A mRNA level both at baseline and 4 hours post CT-1 stimulation ( Figure 6B , right panel). These data indicated that unregulated gp130-STAT3 activation is required for the increase in SCN5A mRNA in SOCS3 cKO cardiomyocytes. 
Hypophosphorylation of TnI (Ser23/24) in SOCS3 cKO Nonfailing Hearts
The absence of enhanced cardiac function under the increased Ca 2ϩ transients in SOCS3 cKO hearts ( Figure 5A ) suggested the presence of abnormalities in myofilament Ca 2ϩ sensitivity that preceded the manifestation of cardiac dysfunction. Because ultrastructure of myofibrils was intact even in the failing hearts ( Figure 2E ), we next focused on the phosphorylation of contractile proteins. We found hypophosphorylation of troponin-I (TnI) (Ser23/24) in SOCS3 cKO nonfailing and failing hearts ( Figure 5D and online-only Data Supplement Figure II, respectively) . This suggested a role for abnormal myofilament Ca 2ϩ sensitivity in the cardiac dysfunction found in SOCS3 cKO mice. Unexpectedly, phosphoprotein kinase A catalytic domain (p-PKA C) that phosphorylates TnI was not decreased in SOCS3 cKO nonfailing and failing hearts ( Figure 5D and online-only Data Supplement Figure II , respectively).
The Importance of gp130 in the Development of Cardiomyopathy in SOCS3 cKO Mice
To determine whether unregulated gp130 activation is a primary cause of cardiomyopathy in SOCS3 cKO mice, we generated cardiac-specific gp130 and SOCS3 double KO mice (gp130&SOCS3 cDKO). We found that the increase in p-STAT3, p-ERK1/2, p-AKT, and p-p38 in SOCS3 cKO hearts was abolished in gp130&SOCS3 cDKO hearts at 15 weeks of age ( Figure 7A ). We next examined the survival curve of gp130&SOCS3 cDKO mice. The double KO mice survived significantly longer than SOCS3 cKO mice, but died at time points that were very similar to cardiac-specific gp130 KO mice (gp130 cKO) ( Figure 7B ). The survival curve of gp130 cKO mice was comparable to that of a previous report. 25 At 33 weeks of age, gp130&SOCS3 cDKO mice showed significantly decreased cardiac function by echocardiography (online-only Data Supplement Figure VI) . Unlike SOCS3 cKO, histological analysis of both gp130&SOCS3 cDKO and gp130 cKO hearts revealed typical cardiomyopathic findings, such as myocyte necrosis and diffuse fibrosis. The heart weight to tibia length ratio (HW/TL) was also significantly increased in both gp130&SOCS3 cDKO and gp130 cKO mice compared with SOCS3 cKO mice ( Figure  7C ). The similarity of cardiac phenotype between gp130 cKO and gp130&SOCS3 cDKO mice, and the clearly distinct cardiac phenotype between SOCS3 cKO and gp130&SOCS3 cDKO mice, demonstrated the importance of gp130 in the development of the cardiac dysfunction in SOCS3 cKO mice.
Discussion
In this study, we sought to determine the pathophysiological role of SOCS3 regulation in the cardiomyocyte using a cardiac-specific SOCS3 KO animal model. We demonstrated that the absence of SOCS3 allows for unregulated activation of gp130 signaling. This led to contractile dysfunction and ventricular arrhythmias accompanied by abnormal myofilament Ca 2ϩ sensitivity and SR Ca 2ϩ overload. We further determined that acute pressure overload in the absence of SOCS3 results in cardiac dysfunction that is associated with increased activation of downstream markers of gp130 signaling ( Figure 3 ). These results demonstrate the apparently important role for homeostatic regulation of gp130 signaling via SOCS3 in the cardiomyocyte (Figure 8 ). It is possible that there are other potential mechanisms that might account for the improvement in the phenotype that occurs with SOCS3 deficiency when gp130 is also absent in the heart. This could include the possibility that complete absence of the gp130 receptor intracellular domain could make other gp130 interacting proteins, such as JAKs and SHP-2, more available to interact with other receptor systems.
Factors that can affect SOCS3 expression level in the cardiomyocyte are poorly understood. We are not aware of any association between SOCS3 gene mutation and cardiomyopathy that has been identified in humans to date. However, decreases in SOCS3 protein and mRNA in failing human hearts have been reported. [15] [16] [17] Furthermore, epigenetic SOCS3 silencing by the hypermethylation of CpG islands in SOCS3 promoter has been reported in many cancer cells. 18, 19 These data indicate that abnormalities in SOCS3 protein expression can occur in the heart. 
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It has been reported that IL-6 stimulation decreases cardiomyocyte contractility through a cardiac nitric oxide synthase (NOS)-dependent mechanism. 7, 26, 27 However, we did not observed a significant increase in NOS activity in SOCS3 cKO failing hearts (data not shown). Furthermore, although chronic IL-6 exposure decreases Ca 2ϩ transients via inducible NOS, 28 we found an increase in Ca 2ϩ transients in SOCS3 cKO cardiomyocytes (Figures 4A and 5A ). These differences suggest that although activation of gp130 signaling can induce contractile abnormalities, underlying mechanisms may be different in the absence of SOCS3 regulation. It has been reported that SOCS3 determines the plasticity of gp130 signaling. Typically, gp130 activation by IL-6 promotes proinflammatory responses; however, in macrophage-specific SOCS3 knockout mice, IL-6 conversely attenuates the inflammatory responses. Furthermore, gp130 stimulation in SOCS3-null macrophages and liver activates transcription of genes not typical of gp130 signaling such as IFN-␥-responsive genes. 20, 29, 30 Similarly, we found an atypical increase in SCN5A mRNA and protein in SOCS3 cKO hearts ( Figure 5D and online-only Data Supplement Figure VA) . The increases in SCN5A mRNA and protein were abolished in gp130 and SOCS3 cDKO hearts (online-only Data Supplement Figure  VB) . Moreover, the activation of gp130 by CT-1 increased SCN5A mRNA only in SOCS3 cKO cardiomyocytes ( Figure  6A ). These data demonstrate that unregulated gp130 activation is required for the augmented expression of SCN5A mRNA and protein. Role of gp130 activation in the development of mortality and cardiomyopathy in SOCS3 cKO mice. A, gp130 signaling activation was examined in gp130&SOCS3 cDKO (cDKO) hearts at 8 and 15 weeks of age. Representative Western blot from 3 independent experiments is shown (left panel). The activation of STAT3, ERK1/2, AKT, and p38 signaling in SOCS3 cKO mice was abolished in the double KO mice (right panels). Expression level was calculated relative to the mean value of wild-type (WT) group (nϭ6 in each group). B, gp130&SOCS3 cDKO survived significantly longer than SOCS3 cKO (Logrank test PϽ0.0001). There was no significant difference in the survival rate between gp130&SOCS3 cDKO and gp130 cKO. C, Histological differences between SOCS3 cKO and gp130&SOCS3 cDKO failing hearts. The transverse section of gp130 cKO (35 weeks old), gp130&SOCS3 cDKO (35 weeks old), and SOCS3 cKO (28 weeks old) failing hearts are shown on the top panels. Hematoxylin-eosin (HE) and MassonTrichrome (MT) staining of the heart tissue from gp130 cKO and gp130&SOCS3 cDKO are shown on the left lower panel. Unlike SOCS3 cKO, significant fibrosis can be observed in both groups. Scale barϭ200 m. Heart weight and tibia length ratio (HW/TL) is shown on the right lower panel. Total five hearts in each group were examined. Error bars are ϮSEM * The SCN5A gene encodes the ␣-subunit of cardiac voltage-gated Na ϩ channel. Evidence is accumulating that SCN5A mutations are associated with not only arrhythmias but also DCM; however, the underlying mechanisms are still obscure. 31 In our preliminary results, the increase in SCN5A protein expression was associated with the enhanced voltagegated Na ϩ current density and [Na ϩ ] i in SOCS3 cKO cardiomyocytes (data not shown). It is well known that an increase in [Na ϩ ] i can negatively affect forward mode NCX activity, leading to an increase in [Ca 2ϩ ] i . 32 Although additional studies with more comprehensive electrophysiological assessments are necessary, but given the minimal histological abnormalities and the normal expression of SR proteins, L-type Ca 2ϩ and NCX1 in SOCS3 cKO cardiomyocytes ( Figure 2E and online-only Data Supplement Figure IV) , we speculate that the increase in SCN5A may, at least in part, be involved in the mechanisms underlying the increase in Ca 2ϩ transients and SR Ca 2ϩ contents in SOCS3 cKO cardiomyocytes. It is well known that SR Ca 2ϩ overload induces CA 2ϩ leak from SR by increasing the open probability of ryanodine receptors. 33 Therefore, SR Ca 2ϩ leak due to the increased SR CA 2ϩ content is thought to be an important factor that mediates triggered activity and arrhythmogenicity in SOCS3 cKO cardiomyoctyes ( Figures 4D, 5B , and 5C).
The relationship between peak [Ca 2ϩ ] i and %sarcomere shortening indicated that there were abnormalities in myofilament Ca 2ϩ sensitivity in SOCS3 cKO cardiomyocytes (Figure 4B) . We found the hypophosphorylation of TnI (Ser23/ 24) in SOCS3 cKO hearts before the mice developed significant cardiac dysfunction ( Figure 5D ). Of the known TnI phosphorylation sites, Ser23/24 are the most well characterized phosphorylation sites affecting myofilament contractility. 34, 35 Indeed, the hypophosphorylation of TnI (Ser23/ 24) is frequently observed in patients with heart failure. 36, 37 Whereas the downregulation and/or desensitization of ␤-adrenergic receptor can induce the hypophosphorylation of TnI (Ser23/24), 38 the increase in p-PKA C in SOCS3 cKO hearts implies that the inactivation of ␤-adrenergic receptor-PKA signaling pathway may not be involved in the hypophosphorylation of TnI (Ser23/24) ( Figure 5D ). However, given the possibility that whole cell PKA catalytic activity may not reflect local and targeted activity for TnI phosphorylation, further studies are necessary to determine whether unregulated gp130 activation is sufficient to change phosphorylation status of TnI in a PKA-independent manner.
Because it has been shown that expression of Cre might induce a toxic effect on the myocardium in certain circumstances, 39 -42 we controlled for such an effect by examining the survival curve of Cre-only mice (ϩ/ϩ, Cre) and cardiac function of cardiac-specific heterozygous SOCS3 KO mice (SOCS3 F/-, Cre). Another potential problem is the timing of SOCS3 gene ablation. Given that Cre expression starts during cardiac development in our system, we could not completely exclude the possibility of myofilament remodeling as an additional factor accelerating cardiac dysfunction in SOCS3 cKO mice. Postnatal SOCS3 ablation in the cardiomyocyte would give us insights into this point.
In conclusion, disruption of SOCS3 regulation in the cardiomyocyte leads to contractile dysfunction and ventricular arrhythmias associated with increases in downstream markers of gp130 activation. Furthermore, the improvement in mortality and cardiac function in the gp130 and SOCS3 double KO, when compared with the SOCS3-deficient hearts, provides strong evidence that at least part of the phenotype in the SOCS3-deficient hearts is secondary to unregulated activation of gp130 signaling. Our results are the first to support the possibility that abnormalities in SOCS3 regulation of cardiac gp130 signaling could be an important disease mechanism underlying fatal arrhythmias and DCM in humans.
SUPPLEMENTAL MATERIAL Supplementary Methods
Histology and Transverse electron microscopy (TEM). Hematoxylin and eosin (HE), Masson-trichrome (MT) staining were performed using 10-um paraffin-embedded sections. For TEM, Karnovsky solution, a mixture of 4% glutaraldehyde and 6% formaldehyde was injected into coronary artery by retrograde perfusion to maintain the ultrastructure of the heart. Quantitative PCR. Total RNA was extracted with Trizol solution (Sigma) followed by reverse transcription with oligo-dT primer using SuperScript III First-Strand (Invitrogen).
Quantitative PCR was performed using TaqMan Gene Expression Assay (Applied Biosystems) according to manufacturer's instruction. 
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Supplementary Figure 2
Expression levels of indicated proteins were examined in SOCS3 cKO failing hearts (28 weeks old, n=5) by western-blot. Representative western-blot from three independent experiments is shown. *p<0.05 comparing SOCS3 cKO with WT.
Supplementary Figure 3
There were no significant differences in STAT3, ERK1/2 and AKT activation between WT and SOCS3 cKO hearts at 10 days post Sham operation (n=5 in each group).
Supplementary Figure 4
The expression level of proteins that can affect Ca 
Supplementary Figure 6
Cardiac function of cardiac-specific gp130 & SOCS3 KO mice (cDKO) was examined by echocardiography at 33 weeks of age (n=4 in each group). *p<0.05 comparing cDKO mice with WT.
